☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Roche
Roche to Acquire Poseida Therapeutics for ~$1.5B
November 26, 2024
Roche Reports 1-Year Data from P-IV (ELEVATUM) Study of Vabysmo (Faricimab) in Patients with Diabetic Macular Edema (DME)
October 21, 2024
Roche Highlights 2-Years Data from RAINBOWFISH Trial of Evrysdi for Treating Children with Spinal Muscular Atrophy (SMA) at WMS 20...
October 14, 2024
Roche’s Reports the US FDA’s Approval of Itovebi as a Treatment for HR+ and HER2- breast cancer with a PIK3CA mutation
October 11, 2024
Roche’s Ventana CLDN18 (43-14A) RxDx Assay Receives CE Mark Approval to Diagnose G/GEJ Cancer Patients with CLDN18 Protein Express...
October 10, 2024
Roche Reports Topline Data from P-III (REGENCY) Trial of Gazyva/Gazyvaro (Obinutuzumab) for Treating Lupus Nephritis
September 26, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.